Endovesical instillation of platelet rich fibrin for treatment of interstitial cystitis: case report of two patients

Abstract

Interstitial cystitis, also called painful bladder syndrome, is a chronic condition causing bladder pain and sometimes pelvic pain. The exact cause of interstitial cystitis is not known. Often, signs and symptoms are hard to elucidate and no single treatment works for everyone. We report two cases of patients affected by interstitial cystitis treated with endovesical instillation of platelets rich fibrin (PRF). PRF is an autologous component that promotes angiogenesis, tissue growth and repair. This report presents the safety and the efficacy of PRF instillations in controlling clinical symptoms and restoring quality of life.

Keywords

Bladder pain syndrome / cystoscopy / interstitial cystitis / platelet rich fibrin

References

[1] Curhan GC,Hunter DJ,Stampfer MJ.Epidemiology of interstitial cystitis: a population based study..J Urol1999;161:549-52

[2] Teichman JM.The role of the bladder surface in interstitial cystitis/painful bladder syndrome..Can J Urol2007;14:3599-607

[3] Fall M,Aldenborg F.Chronic interstitial cystitis: a heterogeneous syndrome..J Urol1987;137:35-8

[4] American Urological Association (AUA) treatment guidelines 2011. Available from: http://www.auanet.org/guidelines [Last accessed on 4 Dec 2017]

[5] Mankad PS.The role of fibrin sealants in hemostasis..Am J Surg2001;182:S21-8

[6] Jackson MR.Fibrin sealants in surgical practice: an overview..Am J Surg2001;182:S1-7

[7] Schwartz M,Hirose R,Sher L,Colonna JO2nd,Mirza D,Rees M.Comparison of a new fibrin sealant with standard topical hemostatic agents..Arch Surg2004;139:1148-54

[8] Fattahi T,Caldwell GT.Clinical applications of fibrin sealants..J Oral Maxillofac Surg2004;62:218-24

[9] Hong YM.The use of hemostatic agents and sealants in urology..J Urol2006;176:2367-74

[10] Serrano Frago P,Gil Martínez P,Mallén Mateo E,Rioja Sanz LA.Treatment of hemorrhagic cystitis secondary to cyclophosphamide. Literature review with regard to a case..Actas Urol Esp2005;29:230-3(in Spanish)

[11] O'Leary MP,Fowler FJ, Jr..Hard measures of subjective outcomes: validating symptom indexes in urology..J Uro11992;148:1546-8, discussion 1564

[12] Keller ML,Neider RS.Measurement of symptoms of interstitial cystitis. A pilot study..Urol Clin North Am1994;21:67-71

[13] Kleinbaum DG,Morgenstem H.Epidemiologic Research: Principles and Quantitative Methods1982;New YorkLifetime Learning Publications152

[14] Deyo RH,Patrick D.Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation..Controlled Clin Trials1991;12:S142-58

[15] Cronbach LJ.Coefficient alpha and the internal structure of tests..Psychometrika1951;16:297A

[16] Wasson JH,Bruskewitz RC,Keller AM.A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia..N Engl J Med1995;332:75-9

[17] Ware JEJr.The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection..Med Care1992;30:473-83

[18] Apolone G,Ware JE.Questionario sullo stato di salute SF-36. Manuale d'uso e guida all'interpretazione dei risultati.1997;MilanoGuerini e associati

[19] Dodd RA,Holm NE,Hollingsbee DA.The Vivostat application system: a comparison with conventional fibrin sealant application systems..Technol Health Care2002;10:401-11

[20] Srikrishna S,Cardozo L.Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse..Int Urogynecol J2010;21:523-8

[21] Diokno AC,Sekiguchi Y.Interstitial cystitis, gynecologic pelvic pain, prostatitis, and their epidemiology..Int J Urol2003;10:S3-6

[22] Offiah I,O'Reilly BA.Interstitial cystitis/bladder pain syndrome: diagnosis and management..Int Urogynecol J2013;24:1243-56

[23] van de Merwe JP,Bouchelouche P,Cervigni M,Elneil S,Hohlbrugger G,Mortensen S,Osborne JL,Richter B,Sairanen J,Wyndaele JJ.Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal..Eur Urol2008;53:60-7

[24] Hunner GL.A rare type of bladder ulcer in women: report of cases..Trans South Surg Gynecol Assoc1914;27:247-92

[25] Johansson SL.Clinical features and spectrum of light microscopic changes in interstitial cystitis..J Urol1990;143:1118-24

[26] Lamm DL.Inflammatory carcinoma of the bladder and interstitial cystitis..J Urol1977;117:49-51

[27] Tirindelli MC,Sergi F,Cudillo L,Postorino M,Greco R,Arcese W.Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation..Transfusion2009;49:170-5

[28] Cheng L,Bostwick DG.Bladder pathology. In: Interstitial cystitis.2012;Hoboken (NJ)Wiley-Blackwell22-5

[29] Lynes WL,Shortliffe LD.The histology of interstitial cystitis..Am J Surg Pathol1990;14:969-76

[30] Kim HJ.Update on the pathology and diagnosis of interstitial cystitis/bladder pain syndrome: a review..Int Neurourol J2016;20:13-7 PMCID:PMC4819162

[31] American Urological Association (AUA) treatment guidelines 2016. Available from: http://www.auanet.org/guidelines [Last accessed on 4 Dec 2017]